Richard Peters

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Albert W. Vanderlaan, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Peters:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. Director Common Stock 3,119 $5,052 $1.62 05 Jun 2025 Direct
KINETA, INC./DE Director Common Stock 0 $0 $0.3300 30 Jun 2025 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4,185 20 Jun 2024 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4,185 05 Jun 2025 Direct
KINETA, INC./DE Director Stock Option (Right to Buy) 0 30 Jun 2025 Direct

Insider Reports Filed by Richard Peters

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KANT KINETA, INC./DE 30 Jun 2025 3 $0 4 Director 02 Jul 2025, 16:26
KANT KINETA, INC./DE 23 Jun 2025 4 +$6,414 4 Director 25 Jun 2025, 21:54
APRE Aprea Therapeutics, Inc. 05 Jun 2025 2 $0 4 Director 09 Jun 2025, 16:06
KANT KINETA, INC./DE 04 Sep 2024 1 $0 4 Director 05 Sep 2024, 16:21
APRE Aprea Therapeutics, Inc. 20 Jun 2024 2 $0 4 Director 21 Jun 2024, 16:18
APRE Aprea Therapeutics, Inc. 23 Aug 2023 2 $0 4 Director 24 Aug 2023, 21:50
KANT KINETA, INC./DE 12 Apr 2023 2 $0 4 Director 14 Apr 2023, 16:11
KANT KINETA, INC./DE 16 Dec 2022 1 -$3,592 4 Director 20 Dec 2022, 19:59
KANT YUMANITY THERAPEUTICS, INC. 02 Dec 2022 1 -$18,418 4 President and CEO, Director 06 Dec 2022, 15:56
APRE Aprea Therapeutics, Inc. 28 Jul 2022 2 $0 4 Director 01 Aug 2022, 17:05
KANT YUMANITY THERAPEUTICS, INC. 05 Jul 2022 1 -$8,476 4 President and CEO, Director 06 Jul 2022, 16:54
KANT YUMANITY THERAPEUTICS, INC. 03 Jun 2022 1 -$12,192 4 President and CEO, Director 06 Jun 2022, 21:45
KANT YUMANITY THERAPEUTICS, INC. 28 Mar 2022 1 -$19,775 4 President and CEO, Director 30 Mar 2022, 16:05
KANT YUMANITY THERAPEUTICS, INC. 01 Dec 2021 1 $0 4 President and CEO, Director 03 Dec 2021, 15:15
KANT YUMANITY THERAPEUTICS, INC. 02 Jul 2021 2 -$50,192 4 President and CEO, Director 07 Jul 2021, 16:44
APRE Aprea Therapeutics, Inc. 30 Jun 2021 2 $0 4 Director 01 Jul 2021, 19:02